AVITA Medical Submits Response to FDA, Resuming Review Clock for RECELL GO PMA SupplementGlobeNewsWire • 02/29/24
AVITA Medical Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial GuidanceGlobeNewsWire • 02/22/24
AVITA Medical to Announce Fourth Quarter and Full Year 2023 Financial ResultsGlobeNewsWire • 02/01/24
AVITA Medical Announces Exclusive Distribution Agreement with Stedical ScientificGlobeNewsWire • 01/10/24
AVITA Medical Announces Preliminary 2023 Financial Highlights, Provides 2024 Financial Guidance and Business UpdateGlobeNewsWire • 01/10/24
AVITA Medical to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/04/24
AVITA Medical Positioned For Stellar 2024 With Skin Repair Innovation MomentumSeeking Alpha • 12/20/23
AVITA Medical to Present at the Piper Sandler 35th Annual Healthcare ConferenceGlobeNewsWire • 11/21/23
AVITA Medical Reports Third Quarter Financial Results with 51% Revenue Growth over the Same Period the Prior YearGlobeNewsWire • 11/09/23
AVITA Medical Announces Distribution Partnership with PolyMedics Innovations to Expand to EuropeGlobeNewsWire • 11/09/23
AVITA Medical Receives Best Product Award at the American Association for the Surgery of TraumaGlobeNewsWire • 09/25/23